Similar Posts
Constellium SE: Favorable Metal Price Dynamics Drive Record Quarterly EBITDA
Company Overview Ticker: CSTM(NYSE) Headquarters: Paris, France Founded: 2017 CEO: Ingrid Joerg Industry: Non-Energy Minerals Core Business Constellium is a global leader in advanced aluminum products, supplying lightweight, high-performance materials that help customers improve fuel efficiency, reduce emissions, and enhance…This report is available to MarketFacts members.Log in to read this report
XP Inc.: Disrupting Brazil’s Investment Industry Through Fintech Innovation
XP Inc. is one of the largest independent financial services platforms in Brazil, providing investment products, brokerage services, and wealth management through a technology-driven ecosystem.
What makes Hannon Armstrong (XNYS:HASI) a textbook buy stock?
Hannon Armstrong Sustainable Infrastructure Capital Inc (XNYS: HASI) finances the US energy markets using debt and equity. The company’s investments are divided into energy-efficiency initiatives and renewable-energy projects. Energy-efficiency initiatives lower the energy usage and expense of a building or facility by improving or installing building components such as heating, ventilation, and air conditioning systems, lighting, energy controls, roofs, windows, building shells, and heat and power systems. Renewable-energy projects use greener energy sources like solar and wind to create electricity. The organization also offers finance for other initiatives to improve energy efficiency and the environment.
Enbridge Inc. (TSX: ENB): Reliable Long-Term Investment, Strong Dividends
Enbridge Inc. (TSX: ENB), headquartered in Calgary, Alberta, is a leading North American energy infrastructure company founded in 1949. It operates the world’s longest and most complex crude oil and liquids transportation system, and it also has extensive natural gas transmission, distribution, and storage facilities.
Introducing HP Inc. (NYSE: HPQ), a tech giant born from Hewlett-Packard’s 2015 split
HP Inc. (NYSE: HPQ) is a multinational information technology company that was formed in 2015 as a result of the split of the original Hewlett-Packard Company. The split led to the creation of two separate entities: HP Inc. and Hewlett Packard Enterprise (HPE). HP Inc. focuses on personal computing and printing products, while HPE is dedicated to enterprise solutions and services.
Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?
Protagonist Therapeutics, Inc.(XNAS:PGTX) is a biopharmaceutical company that discovers and develops peptide based therapeutic drugs to address hematology and blood disorders, as well as inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 antagonist peptide, which is currently in Phase II clinical trials for the treatment of inflammatory bowel disease (IBD); and PN-235, an interleukin-23 receptor antagonist for the treatment of both IBD and non-IBD indications. A license and collaboration agreement has been signed between the company and Janssen Biotech Inc.